Full Press Release Details
ANI Pharmaceuticals Schedules Conference
Third Quarter 2014 Financial Results
BAUDETTE, Minnesota (October 27, 2014) - ANI Pharmaceuticals,
Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results
on Monday, November 3, 2014, before the opening of the U.S. financial markets. The earnings press release will be accessible through
the Investor Relations section of the Company's website, www.anipharmaceuticals.com.
Arthur S. Przybyl, President and Chief Executive Officer, and
Charlotte C. Arnold, Vice President and Chief Financial Officer, also plan to host a conference call to review those results starting
at 10:30am, Eastern Time on Monday, November 3, 2014. The call will be open to the public and can be accessed through a conference
line by dialing (855) 582-8078. The conference ID is 17132754.
A recording of the conference call will be available within
two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the
replay, dial (855) 859-2056. The access code for the replay is
ANI Pharmaceuticals, Inc. (the "Company" or "ANI")
is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids,
and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.
For more information about ANI, please contact: